Literature DB >> 28447503

1,6-O,O-Diacetylbritannilactone suppresses activation of mast cell and airway hyper-responsiveness.

Meihua Jin1, Sungun Kim2, Nan Qin3, Xi Chen1,4, Ning Ji1, Sheng-An Tang1, Dexin Kong1,3, Eunkyung Lee2, Hongquan Duan1,3.   

Abstract

Mast cells play critical roles in allergic disorders such as atopic dermatitis and allergic asthma. The aim of this study was to investigate the anti-inflammatory and anti-asthmatic activities of 1,6-O,O-diacetylbritannilactone (OODBL) isolated from Inula japonica Thunb. (I. japonica) in a murine asthma model and bone marrow-derived mast cells (BMMCs). In an ovalbumin-induced asthma model, OODBL administration attenuated the airway hyper-responsiveness induced by aerosolized methacholine and serum IgE level in asthmatic mice. In vitro system, we found that OODBL reduced leukotriene C4 production and degranulation through the suppression of cytosolic phospholipase A2 phosphorylation and phospholipase Cγ-mediated Ca2+ influx in IgE/antigen-stimulated BMMCs. Taken together, OODBL may have therapeutic potential in the treatment of allergic diseases such as asthma.

Entities:  

Keywords:  OODBL; asthma; inflammation; leukotriene C4; mast cell degranulation

Mesh:

Substances:

Year:  2017        PMID: 28447503     DOI: 10.1080/08923973.2017.1318911

Source DB:  PubMed          Journal:  Immunopharmacol Immunotoxicol        ISSN: 0892-3973            Impact factor:   2.730


  2 in total

1.  1, 6-O, O-Diacetylbritannilactone from Inula britannica Induces Anti-Tumor Effect on Oral Squamous Cell Carcinoma via miR-1247-3p/LXRα/ABCA1 Signaling.

Authors:  Shaohua Zheng; Lihua Li; Na Li; Yi Du; Nan Zhang
Journal:  Onco Targets Ther       Date:  2020-10-29       Impact factor: 4.147

2.  Spinacetin Suppresses the Mast Cell Activation and Passive Cutaneous Anaphylaxis in Mouse Model.

Authors:  Ning Ji; Shunli Pan; Chen Shao; Yufen Chen; Zhe Zhang; Ran Wang; Yuling Qiu; Meihua Jin; Dexin Kong
Journal:  Front Pharmacol       Date:  2018-07-30       Impact factor: 5.810

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.